Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 3/2007

01.06.2007

Paper-based dosing algorithms for maintenance of warfarin anticoagulation

verfasst von: Sarah E. Wilson, Lorrie Costantini, Mark A. Crowther

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

We examined the quality of anticoagulation produced by two paper-based warfarin dosing algorithms in a randomized clinical trial of warfarin therapy. Fifty-eight patients were randomized to receive warfarin at a target international normalized ratio (INR) range of 2.1–3.0 and were followed for an average of 2.7 years. As a proportion of total patient-time, the percentage of time spent above, within, and below the therapeutic range was 11%, 71%, and 19% respectively. Fifty-six patients were randomized to receive warfarin at a higher target INR range (3.1–4.0) and had INRs within the therapeutic range for 40% of total patient time. We conclude that the performance, minimal cost, and ease-of-use of these algorithms make them well-suited for patient management within primary-care and research settings.
Literatur
1.
Zurück zum Zitat Samsa GP, Matchar DB, Goldstein LB et al (2000) Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Med Res 160:967–973 Samsa GP, Matchar DB, Goldstein LB et al (2000) Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Med Res 160:967–973
2.
Zurück zum Zitat McMahan DA, Smith DM, Carey MA, Zhou XH (1998) Risk of major hemorrhage for outpatient treatment with warfarin. J Gen Intern Med 13:311–316PubMedCrossRef McMahan DA, Smith DM, Carey MA, Zhou XH (1998) Risk of major hemorrhage for outpatient treatment with warfarin. J Gen Intern Med 13:311–316PubMedCrossRef
3.
Zurück zum Zitat Ansell J, Hirsh J, Poller L et al (2004) The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:204S–233SPubMedCrossRef Ansell J, Hirsh J, Poller L et al (2004) The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:204S–233SPubMedCrossRef
4.
Zurück zum Zitat Dalere GM, Coleman RW, Lum BL (1999) A graphic nomogram for warfarin dosage adjustment. Pharmacother 19:461–467CrossRef Dalere GM, Coleman RW, Lum BL (1999) A graphic nomogram for warfarin dosage adjustment. Pharmacother 19:461–467CrossRef
5.
Zurück zum Zitat Fredriks DA, Coleman RW (1991) Nomogram for dosing warfarin at steady state. Clin Pharm 10:923–927PubMed Fredriks DA, Coleman RW (1991) Nomogram for dosing warfarin at steady state. Clin Pharm 10:923–927PubMed
6.
Zurück zum Zitat Crowther MA, Ginsberg JS, Julian J et al (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. NEJM 349:1133–1138PubMedCrossRef Crowther MA, Ginsberg JS, Julian J et al (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. NEJM 349:1133–1138PubMedCrossRef
7.
Zurück zum Zitat Wilson S, Crowther M, Costantini L (1999) An interim analysis to improve precision of warfarin anticoagulation control in a randomized clinical trial. Blood 94:10(S1)–115b Wilson S, Crowther M, Costantini L (1999) An interim analysis to improve precision of warfarin anticoagulation control in a randomized clinical trial. Blood 94:10(S1)–115b
8.
Zurück zum Zitat Rosendaal FR, Cannegeiter SC, van der Meer FJM et al (1993) A method to determine the optimal intensity of oral anticoagulation therapy. Thromb Haemost 69:236–239PubMed Rosendaal FR, Cannegeiter SC, van der Meer FJM et al (1993) A method to determine the optimal intensity of oral anticoagulation therapy. Thromb Haemost 69:236–239PubMed
9.
Zurück zum Zitat Sawicki PT (1999) A structured teaching and self-management program for patient receiving oral anticoagulation: a randomized controlled trial; Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 281:145–150PubMedCrossRef Sawicki PT (1999) A structured teaching and self-management program for patient receiving oral anticoagulation: a randomized controlled trial; Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 281:145–150PubMedCrossRef
10.
Zurück zum Zitat Wilson SJ, Wells PS, Kovacs MJ et al (2003) Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 169:293–298PubMed Wilson SJ, Wells PS, Kovacs MJ et al (2003) Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 169:293–298PubMed
11.
Zurück zum Zitat Hellemons BSP, Langenberg M, Lodder J et al (1999) Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomized controlled trial comparing two intensities of coumarin with aspirin. BMJ 319:958–964PubMed Hellemons BSP, Langenberg M, Lodder J et al (1999) Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomized controlled trial comparing two intensities of coumarin with aspirin. BMJ 319:958–964PubMed
12.
Zurück zum Zitat Hurlen M, Abdelnoor M, Smith P et al (2002) Warfarin, aspirin, or both after myocardial infarction. NEJM 347:969–974PubMedCrossRef Hurlen M, Abdelnoor M, Smith P et al (2002) Warfarin, aspirin, or both after myocardial infarction. NEJM 347:969–974PubMedCrossRef
13.
Zurück zum Zitat Kovacs M, Cruickshank M, Wells PS et al (1999) Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 28:62–68CrossRef Kovacs M, Cruickshank M, Wells PS et al (1999) Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 28:62–68CrossRef
14.
Zurück zum Zitat Gedge J, Orme S, Hampton KK, Channer KS, Hendra TJ (2000) A comparison of a warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing 29:31–34PubMedCrossRef Gedge J, Orme S, Hampton KK, Channer KS, Hendra TJ (2000) A comparison of a warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing 29:31–34PubMedCrossRef
Metadaten
Titel
Paper-based dosing algorithms for maintenance of warfarin anticoagulation
verfasst von
Sarah E. Wilson
Lorrie Costantini
Mark A. Crowther
Publikationsdatum
01.06.2007
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 3/2007
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-006-9025-4

Weitere Artikel der Ausgabe 3/2007

Journal of Thrombosis and Thrombolysis 3/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.